Home/Filings/4/0000908662-08-000105
4//SEC Filing

GTC BIOTHERAPEUTICS INC 4

Accession 0000908662-08-000105

CIK 0000904973operating

Filed

Mar 9, 8:00 PM ET

Accepted

Mar 10, 6:14 PM ET

Size

8.2 KB

Accession

0000908662-08-000105

Insider Transaction Report

Form 4
Period: 2008-03-07
MEADE HARRY
SVP, Transgenic Research
Transactions
  • Award

    Common Stock

    2008-03-07+34,986134,212 total
  • Award

    Stock Option (Right to Buy)

    2008-03-07+25,00025,000 total
    Exercise: $0.63Exp: 2018-03-07Common Stock (25,000 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    22,733
Footnotes (2)
  • [F1]These shares were awarded as part of the Reporting Person's bonus compensation for fiscal year 2007 based on the closing price of $0.63 of the Issuer's Common Stock on March 7, 2008.
  • [F2]5,000 options vested on March 7, 2008. The remaining 20,000 options vest in equal annual installments on each of March 7, 2009, 2010, 2011 and 2012.

Issuer

GTC BIOTHERAPEUTICS INC

CIK 0000904973

Entity typeoperating
IncorporatedMA

Related Parties

1
  • filerCIK 0000904973

Filing Metadata

Form type
4
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 6:14 PM ET
Size
8.2 KB